ServiziMenu principaleHome
You are here: Home > Events > Future Events > Eastern Europe and Balkan Region Refresher Course on Lung Cancer

Eastern Europe and Balkan Region Refresher Course on Lung Cancer

28.03.2019  -  30.03.2019

Budapest, Hungary


Lung cancer


Chairs: T. Cufer, SI – E. Felip, ES

The Refresher Course on Lung Cancer is designed for medical and clinical oncologists of the Eastern Europe and Balkan Region in order to provide an update on the state-of-the-art therapeutic options as well as an overview of the latest advances in the field of lung cancer.

The programme will offer educational lectures covering updates and future directions in diagnostic and treatment approaches in lung cancer; while real life case discussions will provide an ideal opportunity for multidisciplinary discussion. By presenting real life cases young oncologist will get an ideal opportunity to learn on how to best present and discuss their cases.

• Update on pathology and molecular testing in lung cancer
• Update on the latest advances in diagnostic procedures
• Update on the latest advances in targeted therapy and immunotherapy for lung cancer
• Update on modern surgical and radiation therapy approaches in lung cancer
• Get acquainted and put into perspective the latest guidelines
• Learn about the management of specific situations on lung cancer
• Debate controversies and challenges in lung cancer treatment
• Improve practical skills in multidisciplinary discussion and management of lung cancer patients


FACULTY (as of January 2019)
T. Cufer, University Clinic Golnik, SI
E. Felip, Vall d'Hebron University Hospital, Barcelona, ES
G. Galffy, Semmelweis University, Budapest; Pest County Pulmonology Hospital, Törökbálint, HU
M. A. Hoda, Medical University Vienna, Vienna, AT
D. Jovanovic, University Hospital of Pulmonology, Belgrade, RS
I. Kern, University Clinic Golnik, Golnik, SI
G. Ostoros, Semmelweiss University, Budapest, HU

General information

European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
Laura Richetti,
ph +41 91 820 09 51, e-mail: lrichetti@eso.net
Dolores Knupfer, ph +41 91 820 09 52, e-mail: dknupfer@eso.net

The official language will be English. No translation will be available.

Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS).
EACCME credits are recognized by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from ESO.


• Age between 30 and 45 years
• 2-4 years’ experience in oncology
• Involvement in scientific activities and clinical trials
• Fluency in English
• Practicing in Eastern Europe and Balkan Region

Attendance is limited and admittance is by competitive application only.
Successful applicants are granted free registration, lunches and coffee breaks.
Free accommodation at the course venue for arrival on 28 March and departure on 30 March will be provided to participants not residing in the Budapest area.

Priority will be given to applicants who have attended a previous Eastern Europe and Balkan Region Masterclass.

The application outcome will be notified by e-mail by 1st February 2019.



28 March

18:00 Arrivals

29 March

8:45 Welcome address and general introduction
9:00 Screening for lung cancer: pros and cons
M.A. Hoda, AT
9:30 Histopathological diagnosis and classification of lung cancer
I. Kern, SI
10:00 Molecular testing at primary diagnosis and during treatment
I. Kern, SI
10:30 Coffee break
11:00 Radiological methods to assist primary diagnostics and treatment tailoring
Speaker to be confirmed
11:30 Surgery of lung cancer: opportunities and limitations
M.A. Hoda, AT
12:00 Lunch
13:30 Radiotherapy in combination with systemic therapies – a final answer for Stage III disease?
Speaker to be confirmed
14:00 Stereotactic radiotherapy - how to proceed in lung cancer?
Speaker to be confirmed
14:30 Adjuvant/neoadjuvant systemic therapy: Any news?
G. Ostoros, HU
15:00 Coffee break
15:30 Cases presented by participants and discussed by tumor board (faculty) (17:30)

30 March

8:30 Novel targets and targeted therapies in development
E. Felip, ES
9:00 Update on current standards in targeted therapy in advanced NSCLC
T. Cufer, SI
9:30 New frontiers in immunotherapy of lung cancer
E. Felip, ES
10:00 Update on current standards in immunotherapy in NSCLC
G. Galffy, HU
10:30 Coffee break
11:00 Update on current standards in SCLC therapy
G. Ostoros, HU
11:30 Management of oligometastatic lung cancer -dilemmas and opportunities
D. Jovanovic, RS
12:00 Everyday clinical practice questions provided in written form by participants and discussed by tumor board (faculty)
13:00 Closing remarks


Follow us